ConductScience.org, home

Paper · 3108398

Mitogen-driven B cell proliferation and differentiation are not accompanied by hypermutation of immunoglobulin variable region genes.

Manser T. J Immunol, 1987. Cited by 53 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mitogen-driven B cell proliferation and differentiation are not accompanied by hypermutation of immunoglobulin variable region genes. Papers, record 3108398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3108398

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mitogen-driven B cell proliferation and differentiation are not accompanied by hypermutation of immunoglobulin variable region genes.
PubMed
Journal
J Immunol
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
0.93
iCite
Revised in PubMed
2007-11-14
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Manser TT

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B-LymphocytesMajor topic
Immunoglobulin Heavy ChainsMajor topic
Immunoglobulin Variable RegionMajor topic
Animals
Cell Differentiation
Lymphocyte Activation
Mice
Mitogens
Mutation
Time Factors

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
A123739PHS HHSUnited StatesPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
25,288,395Spt5 accumulation at variable genes distinguishes somatic hypermutation in germinal center B cells from ex vivo-activated cells.J Exp Med2014https://conductscience.org/library/papers/25288395PubMed
24,879,790Binding of AID to DNA does not correlate with mutator activity.J Immunol2014https://conductscience.org/library/papers/24879790PubMed
19,202,055The C-terminal region of activation-induced cytidine deaminase is responsible for a recombination function other than DNA cleavage in class switch recombination.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19202055PubMed
16,418,396AID-dependent histone acetylation is detected in immunoglobulin S regions.J Exp Med2006https://conductscience.org/library/papers/16418396PubMed
16,157,688AID from bony fish catalyzes class switch recombination.J Exp Med2005https://conductscience.org/library/papers/16157688PubMed
15,605,247Mutational activity in cell line WEHI-231.Immunogenetics2005https://conductscience.org/library/papers/15605247PubMed
12,633,669Class-switch recombination: after the dawn of AID.Curr Opin Immunol2003https://conductscience.org/library/papers/12633669PubMed
11,854,365Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Smu region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation.J Exp Med2002https://conductscience.org/library/papers/11854365PubMed
10,092,799Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation.J Immunol1999https://conductscience.org/library/papers/10092799PubMed
8,436,910
Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
J Exp Med1993https://conductscience.org/library/papers/8436910PubMed

1 to 10 of 17

See all 17 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data23

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKM17032GENBANK
GENBANKM17033GENBANK
GENBANKM17034GENBANK
GENBANKM17035GENBANK
GENBANKM17036GENBANK
GENBANKM17037GENBANK
GENBANKM17038GENBANK
GENBANKM17039GENBANK
GENBANKM17040GENBANK
GENBANKM17041GENBANK

1 to 10 of 23

See all 23 data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3108398

GET https://conductscience.org/api/papers/v1/3108398/data?page=2